John E Sylvester MD
Urologic Cancer
Medical Director Lakewood Ranch Oncology a division of 21st Century Oncology
Join to View Full Profile
8946 77th Ter ELakewood Ranch, FL 34202
Phone+1 941-907-9053
Fax+1 941-907-9473
Dr. Sylvester is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
- UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Radiation Oncology, 1985 - 1988
- Huntington Memorial HospitalResidency, Internal Medicine, 1984 - 1985
- David Geffen School of Medicine at UCLAClass of 1984
Certifications & Licensure
- SC State Medical License 2025 - 2027
- FL State Medical License 2009 - 2026
- NJ State Medical License 2025 - 2025
- WA State Medical License 1988 - 2023
- CA State Medical License 2010 - 2020
- American Board of Radiology Radiation Oncology
Awards, Honors, & Recognition
- Sarasota Magazine: Top Doctors Castle Connolly, 2012-2014
- CMS Meaningful Use Stage 1 Certification MOSAIQ EMR, Elekta, 2012-2014
Clinical Trials
- Implant and External Radiation for Prostate Cancer With or Without Hormonal Therapy: A Prospective Randomized Trial Start of enrollment: 2004 Aug 01
- Observation of Outcomes and Side Effects of Cesium-131 in Combination With External Beam Radiation for the Treatment of Intermediate to High Risk Prostate Cancer Start of enrollment: 2007 Feb 01
Publications & Presentations
PubMed
- 3 citationsBarrigel Spacer Injection Technique.Glen Gejerman, Martin M Goldstein, Michael Chao, Neal Shore, John Lederer
Practical Radiation Oncology. 2023-08-30 - 34 citationsHyaluronic Acid Spacer for Hypofractionated Prostate Radiation Therapy: A Randomized Clinical Trial.Neil F Mariados, Peter F Orio 3rd, Zvi Schiffman, Thanh John Van, Alexander Engelman
JAMA Oncology. 2023-04-01 - 17 citationsLutetium-177–prostate-specific membrane antigen ligand following radium-223 treatment in men with bone-metastatic castration-resistant prostate cancer: real-world clin...Alton O. Sartor, Christian la Fougère, Markus Essler, Samer Ezziddin, Gero Kramer
Journal of Nuclear Medicine. 2021-06-24
Press Mentions
- 21st Century Oncology Co-Leading Trial to Test Innovative New Treatment for Prostate CancerNovember 5th, 2019
- Pioneer in Prostate Cancer Treatment Leads Data-Driven Approach to Conquer DiseaseFebruary 27th, 2017
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
